CLINICAL-PHARMACOLOGICAL APECTS OF THE USE OF DYDROGESTERONE IN PREGNANCY MAINTENANCE
Abstract
Dydrogesterone is a gestagen with proven pregnancy maintaining efficacy, which has been in common medical practice for more than 15 years in the Russian Federation and for more than 45 years outside of Russia. Dydrogesterone possesses the highest selectivity towards progesterone receptors among all progestins. The presence of an immunomodulating effect is a distinctive pharmacological feature ofdydrogesterone. This review touches upon the metabolism and biological effects ofdydrogesterone, as well as its use in complex pregnancy maintaining therapeutic regimens.
About the Author
E. V. Shikh
Moscow Medical Academy named after I. M. Sechenov
Russian Federation
Chair of Clinical Pharmacology and Internal Disease Propaedeutics of the SEE HPE
Russian Federation
Chair of Clinical Pharmacology and Internal Disease Propaedeutics of the SEE HPE
References
1. Современный взгляд на иммунологические аспекты невынашивания беременности Т.В. Овсянникова, И.С. Сидорова, О.С. Даниова Гинекология. Том 06/N 2/2004
2. Микронизированный прогестерон: вагинальное и пероральное применение. Д.А. Саймон. Проблемы репродукции 2005 г.
3. Гладкова К.А. Роль сенсибилизации к прогестерону в клинике привычного невынашивания беременности. Автореф. дис. канд. мед. наук. М., 2008.
4. Тетруашвили Н.К. Ранние потери беременности (иммунологические аспекты, пути профилактики и терапии). Автореф. дис. доктора мед. наук. М., 2008.
5. Актуальные проблемы невынашивания береенности: цикл клинических лекций. Под ред. В.М.Сидельниковой. М., 1999; 64-6.
6. Невынашивание беременности: этиопатогенез, диагностика и лечение. Под ред. Э.К.Айламазяна. СПб., 2002; 47-9.
7. Cooper M.A., Fehniger ТА, Caligiuri MA. The biology of human natural killer cell subsets. Trends Immunol 2001; 22: 633 40.
8. Dision Ch., Giudice L. Natural killer cells in pregnancy and recurrent pregnancy loss: Endocrine and Immunology perspectives. Endocrine Reviews 2004; 26 (1): 44 62.
9. El Zibdeh M.J. Solvey Farmaceutical Sympoz. Synergy Med. Education 2002; 8-10.
10. El Zibdeh MJ etal. Fertil Steril 1998; 70: 77-8.
11. Genazzani AR. Solvey Farmaceutical Sympoz. Synergy Med. Education 2002; 11-13
12. Seceres Barto J. Solvey Farmaceutical Sympoz. Synergy Med. Education 2002; 4-7.
13. Radhupathy R. et al. Hum Reprod 2000; 15: 713-8.
Review
For citations:
Shikh E.V. CLINICAL-PHARMACOLOGICAL APECTS OF THE USE OF DYDROGESTERONE IN PREGNANCY MAINTENANCE. Obstetrics, Gynecology and Reproduction. 2010;4(2):6-9. (In Russ.)
Views: 513
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
